NARA Discovery
Article Details
← Back to Search Results
Journal Article

The crucial prognostic signaling pathways of pancreatic ductal adenocarcinoma were identified by single-cell and bulk RNA sequencing data

Wenwen Wang; Guo Chen; Wenli Zhang; Xihua Zhang; Manli Huang; Chen Li; Ling Wang; Zifan Lu; Jielai Xia
Human Genetics · Vol. 143, Issue 9-10 · pp. 1109-1129 · 2024

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a malignant tumor with poor prognosis and high mortality. Although a large number of studies have explored its potential prognostic markers using traditional RNA sequencing (RNA-Seq) data, they have not achieved good prediction effect. In order to explore the possible prognostic signaling pathways leading to the difference in prognosis, we identified differentially expressed genes from one scRNA-seq cohort and four GEO cohorts, respectively. Then Cox and Lasso regression analysis showed that 12 genes were independent prognostic factors for PDAC. AUC and calibration curve analysis showed that the prognostic model had good discrimination and calibration. Compared with the low-risk group, the high-risk group had a higher proportion of gene mutations than the low-risk group. Immune infiltration analysis revealed differences in macrophages and monocytes between the two groups. Prognosis related genes were mainly distributed in fibroblasts, macrophages and type 2 ducts. The results of cell communication analysis showed that there was a strong communication between cancer-associated fibroblasts (CAF) and type 2 ductal cells, and collagen formation was the main interaction pathway.

Bibliographic Information

JournalHuman Genetics
PublisherSpringer
Publication Date2024-10-01
Publication Year2024
Volume143
Issue9-10
Pages1109-1129
Document TypeJournal Article
Print ISSN0340-6717
eISSN1432-1203
DOI10.1007/s00439-024-02663-4

Access Information

NARA Access Coverage1964-01-01~Current
Journal Homepagehttps://www.springer.com/journal/439
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.